Claude did not invent scorpion antivenom
Posts from this topic will be added to your daily email digest and your homepage feed.
TL;DR
- An investment research firm, Citrini Research, partnered with Anthropic to test an AI model's ability to create scorpion antivenom.
- The AI model, Claude, generated numerous protein designs, but none proved to be a complete antivenom.
- Experts indicate that while AI can assist in the early stages of drug discovery (like finding potential binders), the subsequent steps of neutralization, safety, and efficacy testing are complex and not yet solved by AI.
- The experiment cost approximately $50,000 for AI compute and $150,000 for lab testing, with Anthropic covering the AI costs.
- Citrini Research declared the experiment a partial success, highlighting investment opportunities in AI-enabled drug discovery, despite not producing a functional drug.